Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-08, Stock:JNJ, The news for the past five days is as follows:
2020-12-01: NEWS1: Activist Shareholders Press Pfizer, J&J, and Other Pharma Companies on Covid Vaccine Price and Access.NEWS2: Want to Invest in Coronavirus Vaccines? Consider This First.NEWS3: New Advances in Treating Difficult Blood Cancers From Johnson & Johnson and Others.NEWS4: I’ve already been injected with a COVID vaccine. This is why I’m cheering for the Novavax underdog.NEWS5: Cramer Weighs In On Peloton, Johnson & Johnson And More.NEWS6: Moderna (MRNA) Seeks Nod for Emergency Use of COVID-19 Vaccine.NEWS7: AstraZeneca (AZN) Forxiga Approved in Japan for Heart Failure.NEWS8: New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Options.NEWS9: Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race.
2020-12-02: NEWS1: Coronavirus update: OWS official says '100% no interference with the FDA'.NEWS2: These Covid-19 Vaccines Are Safe, Right?.NEWS3: North Korea-linked hackers targeted J&J, Novavax in hunt for COVID research.NEWS4: Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic.NEWS5: Should iShares Morningstar LargeCap Value ETF (JKF) Be on Your Investing Radar?.NEWS6: As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial.NEWS7: COVID Vaccine Stocks Update: Where Things Stand Now.
2020-12-03: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Pfizer And Moderna Face Their Biggest Challenge: Vaccinating The World.NEWS3: Johnson & Johnson Names Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General to its Board of Directors.NEWS4: Top Research Reports for Apple, Berkshire Hathaway & Johnson & Johnson.NEWS5: This is why I volunteered for the Novavax COVID-19 vaccine trial, and am still cheering for the underdog.NEWS6: Trump gets measured praise and criticism as COVID-19 vaccines sprint to finish line.NEWS7: J&J (JNJ) Acquires Rights for Hemera Biosciences' Gene Therapy.NEWS8: AbbVie (ABBV) Signs New Cancer/Immunology Deal With Frontier.NEWS9: South Korea Inks COVID-19 Vaccine Deal With AstraZeneca: Reuters.
2020-12-04: NEWS1: The biggest challenges facing vaccine distribution.NEWS2: The Zacks Analyst Blog Highlights: Apple, Berkshire Hathaway, Johnson & Johnson, Lockheed Martin and PNC Financial Services Group.NEWS3: A Trio of Stock Picks for a 'Buy and Hold' Approach.NEWS4: J&J (JNJ) Files BLA for Lung Cancer Candidate Amivantamab.NEWS5: Pharma Stock Roundup: Approval of PFE/BNTX Coronavirus Vaccine in UK, Other Updates.NEWS6: Best Bet in a Down Year: The Dividend Aristocrats.NEWS7: 3 COVID Vaccine Stocks to Invest in for the Long Run.
2020-12-07: NEWS1: People who get injured from COVID-19 vaccines could have a hard time getting compensated.NEWS2: Fate Stock Soars After Novel Natural-Killer Treatment for Cancers Makes a Splash.NEWS3: Race for Multiple Myeloma Drugs Not Moving Stocks — Yet.

Answer: Rise